CN104000889A - 一种用于治疗神经性皮炎的中药 - Google Patents
一种用于治疗神经性皮炎的中药 Download PDFInfo
- Publication number
- CN104000889A CN104000889A CN201410210814.8A CN201410210814A CN104000889A CN 104000889 A CN104000889 A CN 104000889A CN 201410210814 A CN201410210814 A CN 201410210814A CN 104000889 A CN104000889 A CN 104000889A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- neurodermatitis
- traditional chinese
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000009053 Neurodermatitis Diseases 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 6
- 241000468460 Thalictrum aquilegiifolium Species 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 3
- 238000011282 treatment Methods 0.000 claims description 17
- 244000025254 Cannabis sativa Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 208000011502 miliaria alba Diseases 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 abstract description 2
- 241000207894 Convolvulus arvensis Species 0.000 abstract 1
- 235000009072 Mesembryanthemum Nutrition 0.000 abstract 1
- 241000219480 Mesembryanthemum Species 0.000 abstract 1
- 244000292702 Rheum nobile Species 0.000 abstract 1
- 235000006385 Rheum nobile Nutrition 0.000 abstract 1
- 241001533104 Tribulus terrestris Species 0.000 abstract 1
- 206010040882 skin lesion Diseases 0.000 description 12
- 231100000444 skin lesion Toxicity 0.000 description 12
- 208000003251 Pruritus Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000017520 skin disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 235000021152 breakfast Nutrition 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000001314 paroxysmal effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010048768 Dermatosis Diseases 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000008616 guibi-tang Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种用于治疗神经性皮炎的中药,它是由以下重量配比的原料药材制备而成:热痱草12份、茯神10份、日中花16份、塔黄10份、唐松草6份、田旋花10份、蒺藜苗7份。临床实验证明,本发明能够安全有效治疗神经性皮炎。
Description
技术领域
本发明涉及一种中药,具体涉及一种用于治疗神经性皮炎的中药。
背景技术
神经性皮炎又称慢性单纯性苔藓。是以阵发性皮肤瘙痒和皮肤苔藓化为特征的慢性皮肤病。为常见皮肤病,多见于成年人。神经性皮炎属于神经功能障碍性皮肤病。临床表现以皮损对称分布,苔藓样改变,阵发性剧烈搔痒为特征,是一种常见的慢性皮肤病。中医学将本病归为“牛皮癣”“摄领疮”等。
目前用于治疗神经性皮炎的口服成药有:止痒消癣汤、归脾汤及西药西替利嗪等。但药效个体差异太大,治疗效果不理想,无法彻底治愈。
本发明所涉及药材均记载于《中华本草》。
发明内容
本发明旨在提供一种用于治疗神经性皮炎的中药,通过选择合适的药材及其配比,达到安全有效治愈神经性皮炎的目的。
为了达到上述目的,本发明采用以下技术方案:
一种用于治疗神经性皮炎的中药,其特征在于,它是由以下重量配比的原料药材制备而成:热痱草12份、茯神10份、日中花16份、塔黄10份、唐松草6份、田旋花10份、蒺藜苗7份。
下面结合临床实验数据说明本发明的有益效果:
1、一般资料
所有病例均来源发明人于2011年3月~ 2013年3月107医院皮肤科门诊患者,均符合《临床皮肤病学》中有关神经性皮炎的诊断。96例患者中男 36 例,女60例;发病年龄25~ 49岁,平均年龄36岁;病程最短6个月,最长3 年。其临床表现主要以皮肤苔癣样变及剧烈瘙痒为特征。多发生在颈后部或其两侧、肘窝、胭窝、前臂、大腿、小腿及腰骶部等。自觉症状常为阵发性剧烈瘙痒,夜间为甚,多数患者有头晕、失 眠、烦躁易怒、焦虑不安等神经衰弱的症状。
排除标准:①皮损合并细菌或真菌感染者;②妊娠或哺乳期妇女;③入选前1周内局部用过糖皮质激素药物,或服用过抗组胺类药物者;④1个月内系统应用过糖皮质激素类药物者;⑤已知对研究药及其基质成分过敏者;⑥有慢性肝、肾疾病或其他严重病患者;⑦有糖尿病或严重免疫功能低下者。96例患者均符合上述纳入标准。
2、试验方法
口服本发明按照具体实施例1制得的煎剂,每日3次。4周一个疗程。
治疗期间的注意事项:治疗期间生活规律,忌辛辣刺激、腥发之品,戒除烟酒嗜好。
2.2观察项目:主要观察治疗前后患者皮损和自觉症状的变化情况,包括皮损面积、皮损程度和瘙痒程度的变化情况。
3、疗效标准与治疗结果
3.1疗效标准
参照《中药新药临床研究指导原则》以皮损范围、形态及瘙痒累计积分,计算疗效率并进行疗效判定。
疗效率=[(治疗前积分一治疗后积分)/治疗前积分]×100%进行计算。
临床痊愈:皮损全部消退,瘙痒感消失,疗效率达100%;
显效:皮损消退70%以上,痒感明显减轻,疗效率达70%以上 ;
有效:皮损部消退30%以上,瘙痒感减轻,疗效率达30%以上 ;
无效:皮 损消退不足30%,或皮损虽然减轻较多但仍不断有新皮损出现,疗效率未达30%。
3.2治疗统计结果
96例中临床痊愈40例,显效32例,有效16例,无效8例,总有效率为 91.7%。所有病例治疗期间未见明显不良反应。
具体实施方式
为了更好地理解和实施本发明,下面结合具体实施例进一步说明本发明。
具体实施例1
称取:热痱草12克、茯神10克、日中花16克、塔黄10克、唐松草6克、田旋花10克、蒺藜苗7克;加8倍量水,煎煮1.5小时,过滤;滤渣加6倍量水,煎煮1小时,过滤;合并滤液,浓缩至450 mL,,即得符合正常成人一天用量的煎剂。
用于治疗神经性皮炎。口服,每日分早中晚三餐后半小时服用。
具体实施例2
称取:热痱草12克、茯神10克、日中花16克、塔黄10克、唐松草6克、田旋花10克、蒺藜苗7克;加10倍量水,煎煮2小时,过滤;滤渣加8倍量水,煎煮1.5小时,过滤;合并滤液,浓缩,干燥,包装,即得符合正常成人一天用量的散剂。
用于治疗神经性皮炎。口服,每日分早中晚三餐后半小时服用。
具体实施例3
称取:热痱草12克、茯神10克、日中花16克、塔黄10克、唐松草6克、田旋花10克、蒺藜苗7克;加6倍量水,煎煮3次,每次煎煮1小时,合并煎煮液,浓缩,再加入适量糊精和矫味剂,按照本领域常规工艺制粒,包装,即可制得符合正常成人一天用量的颗粒剂。
用于治疗神经性皮炎。口服,每日分早中晚三餐后半小时服用。
Claims (1)
1.一种用于治疗神经性皮炎的中药,其特征在于,它是由以下重量配比的原料药材制备而成:热痱草12份、茯神10份、日中花16份、塔黄10份、唐松草6份、田旋花10份、蒺藜苗7份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410210814.8A CN104000889B (zh) | 2014-05-19 | 2014-05-19 | 一种用于治疗神经性皮炎的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410210814.8A CN104000889B (zh) | 2014-05-19 | 2014-05-19 | 一种用于治疗神经性皮炎的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104000889A true CN104000889A (zh) | 2014-08-27 |
CN104000889B CN104000889B (zh) | 2015-07-08 |
Family
ID=51361978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410210814.8A Expired - Fee Related CN104000889B (zh) | 2014-05-19 | 2014-05-19 | 一种用于治疗神经性皮炎的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104000889B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393916A (zh) * | 2013-08-02 | 2013-11-20 | 赵洪乾 | 一种治疗皮炎的外用药膏及制备方法 |
-
2014
- 2014-05-19 CN CN201410210814.8A patent/CN104000889B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393916A (zh) * | 2013-08-02 | 2013-11-20 | 赵洪乾 | 一种治疗皮炎的外用药膏及制备方法 |
Non-Patent Citations (1)
Title |
---|
仓田等: "陈彤云治疗神经性皮炎经验", <<中医杂志>>, vol. 54, no. 5, 31 March 2013 (2013-03-31), pages 380 - 381 * |
Also Published As
Publication number | Publication date |
---|---|
CN104000889B (zh) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105381132A (zh) | 一种用于治疗甲状腺结节的药物 | |
CN104800597A (zh) | 一种治疗咽喉炎的中药组合物 | |
CN103893613B (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
CN102697911A (zh) | 一种治疗失眠的中药组合物 | |
CN104000889B (zh) | 一种用于治疗神经性皮炎的中药 | |
CN104547400A (zh) | 一种用于治疗痛经的药物 | |
CN102784235A (zh) | 一种治疗口腔溃疡的药物及其制备方法 | |
CN102293880B (zh) | 治疗褥疮的外用中药制剂及制备方法 | |
CN105255676A (zh) | 枸杞酒及其制备方法和应用 | |
CN104524085A (zh) | 一种用于治疗原发性痛经的药物 | |
CN104306676A (zh) | 一种用于治疗产后便秘的中药或者保健品 | |
CN103705618B (zh) | 治疗脚气病的药物 | |
CN104147168B (zh) | 一种用于治疗压疮的中药 | |
CN104173513B (zh) | 一种用于治疗产后便秘的中药或者保健品 | |
CN103638159B (zh) | 治疗急性乳腺炎的外用中药制剂 | |
CN102178851B (zh) | 治疗神经性头痛的药物 | |
CN102772762B (zh) | 一种治疗皮肤病的中药有效部位组合物及其制备方法 | |
CN105031526A (zh) | 一种治疗神经性皮炎的中药及其制备方法 | |
CN105288436A (zh) | 一种用于治疗慢性湿疹的药物 | |
CN105267321A (zh) | 一种用于治疗痛风性关节炎的药物 | |
CN104352852A (zh) | 一种治疗阴虚火旺证型不寐病的中药组合物 | |
CN104096038A (zh) | 一种治疗偏头痛的中药酒 | |
CN103656218A (zh) | 一种治疗急性湿疹的外用药 | |
CN104055885A (zh) | 一种用于治疗神经性皮炎的中药 | |
CN102552581B (zh) | 一种治疗失眠症的药剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210713 Address after: 061000 No. 152, Zhongying village, Benzhai Township, Xian County, Cangzhou City, Hebei Province Patentee after: Kong Lingzhong Address before: 239000 No. 12, Shuixi village, Shuikou Town, Shuikou Town, Lai An county, Chuzhou, Anhui Patentee before: Liu Xinxia |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150708 |